The Vanguard Group 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 2:33 pm Unchanged |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 235,294 5.850% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:08 pm Unchanged |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 235,294 5.850% |
0 (Unchanged) |
Filing |
| 2024-11-04 12:11 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 235,294 5.850% |
-46,472 (-16.49%) |
Filing |
| 2024-02-13 5:04 pm Sale |
2023-12-29 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 281,766 7.160% |
-95,997 (-25.41%) |
Filing |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 377,763 10.050% |
2,355 (+0.63%) |
Filing |
| 2022-03-09 08:44 am Purchase |
2022-02-28 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 375,408 10.090% |
13,960 (+3.86%) |
Filing |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 361,448 9.750% |
58,850 (+19.45%) |
Filing |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 302,598 8.310% |
21,461 (+7.63%) |
Filing |